Analisis efektivitas biaya penggunaan antibiotik empiris kombinasi seftriakson-azitromisin dengan levofloksasin tunggal pada pasien pneumonia komunitas rawat inap di RSUP Persahabatan = Cost effectiveness analysis of the use of empirical antibiotics comparing combination of ceftriaxone azithromycin with levofloxacin in community acquired pneumonia patients in RSUP Persahabatan

Cost Effectiveness Analysis Terapi Antibiotik pada Pasien Geriatri dengan Pneumonia Komunitas di Ruang Rawat Inap RSUPN Cipto Mangunkusumo

Analisis efektivitas biaya antibotik seftriakson dan levofloksasin pada pasien pneumonia komunitas rawat inap di RS Karya Bhakti Pratiwi tahun 2017 = Cost effectiveness analysis of antibiotic ceftriaxone and levofloxacin on inpatient community acquired pneumonia in RS Karya Bhakti Pratiwi in 2017

Analisis Efektivitas Biaya Levofloksasin Dibandingkan Kombinasi Azitromisin-Seftriakson Pada Pasien Pneumonia Komunitas Rawat Inap di RSUD Tangerang Selatan Tahun 2020-2022 = Cost-Effectiveness Analysis of Levofloxacin Compared to the Combination of Azithromycin-Ceftriaxone on Community Acquired Pneumonia Inpatients at South Tangerang Hospital in 2020-2022

Validasi Skor DRIP (Drug Resistance in Pneumonia) sebagai Prediktor Kegagalan Antibiotik Empirik pada Pasien Community Acquired Pneumonia (CAP) di RSUPN DR. Cipto Mangunkusumo Jakarta = Validation of Drug Resistance in Pneumonia (DRIP) Score as Empirical Antibiotic Failure Predictor in Community Acquired Pneumonia (CAP) Patients in Cipto Mangunkusumo Hospital